Skip to main content

LURASIDONE

Tracking # 20-811581

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

LURASIDONE IS A MEDICATION USED IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DEPRESSION. IT IS IN THE BENZISOTHIAZOLE CLASS OF MEDICATIONS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR LURASIDONE AS A VALUABLE AGENT IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DEPRESSION. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS, E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, AND RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DEPRESSION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.25h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.25h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.25h AMA Category I

Physician Assistant

1.25h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.25h AMA Category I